Indian pharma companies go bullish on overseas buys Meghna A Singhania18 Sept 2015 12:14 PM ISTAccording to a research report from Jefferies states, Â the major player among the Indian pharma companies have now entered the phase of global...
Lupin gets approval from USFDA for ulcer drug Pooja Bhatia Bhatia29 Aug 2015 11:05 AM ISTLupin has received an approval from USFDA to market a generic drug in the US to treat ulcerDrug firm Lupin has received a nod from US Food and Drug...
USFDA approval for anti-cholesterol tablet by Lupin Meghna A Singhania21 Aug 2015 2:55 PM ISTLupin will now market a generic version of Teva’s Fenofibrate Tablets in the American marketPharmaceutical major Lupin Ltd recently announced that it...
Lupin opens R&D facility in Florida to develop inhalation products in US Meghna A Singhania8 Aug 2015 12:43 PM ISTNEW DELHI: Drug major Lupin today said it has opened a research and development centre for inhalation products in Florida, the US.The facility at...
Lupin buys US generics firm Gavis for $880 million Meghna A Singhania24 July 2015 10:47 PM ISTNEW DELHI: In a large victory for the Indian Multinationals, Drug major Lupin today said it is acquiring US-based Gavis for USD 880 million (over Rs...
Lupin acquires Russian drug firm Biocom Shreya Garg12 July 2015 11:05 AM ISTLupin, India's fifth largest drug maker, has entered the Russian market by acquiring 100% stake in Biocom, a fast-growing generic pharmaceuticals...
